Galecto competitorsClear all

Galecto's top competitors include GlycoMimetics, Supernus Pharmaceuticals, Metabomed and ITeos Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Galecto
Galecto
Galecto Biotech is a company that develops small molecules for the treatment of severe diseases, including fibrosis, cancer, and inflammation.
GlycoMimetics
GlycoMimetics
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
Supernus Pharmaceuticals
Supernus Pharmaceuticals
Supernus Pharmaceuticals is focused on developing and commercializing products for the treatment of central nervous system.
Metabomed
Metabomed
Metabomed is a drug discovery company in the field of cancer metabolism.
ITeos Therapeutics
ITeos Therapeutics
ITeos Therapeutics is a biopharmaceutical company whose work is dedicated to designing and developing next generation immunotherapies.
Founding Date
Founding Date
2011
Founding Date
2003
Founding Date
2005
Founding Date
N/A
Founding Date
2011
Type
Type
Public
Type
Public
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
København, DK HQ
Locations
Rockville, US HQ
Locations
Rockville, US HQ
Rockville, US
Locations
Yavne, IL HQ
Cambridge, US
Locations
Charleroi, BE HQ
Cambridge, US
Employees
Employees
28
Employees
5025% increase
Employees
4486% increase
Employees
19
Employees
886% increase
Valuation ($)
Valuation ($)
89.7 m
Valuation ($)
105 m
Valuation ($)
1.8 b
Valuation ($)
N/A
Valuation ($)
N/A
Alexa Website Rank
Alexa Website Rank
200609
Alexa Website Rank
N/A
Alexa Website Rank
203693
Alexa Website Rank
N/A
Alexa Website Rank
214677
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3.1
Employee Rating
4
Employee Rating
4

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$10.2m (FY, 2020)
Revenue (est.)
$520.4m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
($34.8m) (FY, 2020)
Net income
($51m) (FY, 2020)
Net income
$127m (FY, 2020)
Net income
N/A
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 18m (over 5 years ago)
Latest funding round
$ 125m (over 1 year ago)
Total funding raised
Total funding raised
$ 64m
Total funding raised
$ 101.8m
Total funding raised
$ 42m
Total funding raised
$ 18m
Total funding raised
$ 215m
For sources of this data, please see the company profile

View company profiles

GlycoMimetics
HQ
Rockville, US
Employees
50↑ 25% increase

GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.

View company
Supernus Pharmaceuticals
HQ
Rockville, US
Employees
448↑ 6% increase

Supernus Pharmaceuticals is focused on developing and commercializing products for the treatment of central nervous system.

View company
Metabomed
HQ
Yavne, IL
Employees
19

Metabomed is a drug discovery company in the field of cancer metabolism.

View company
ITeos Therapeutics
HQ
Charleroi, BE
Employees
88↑ 6% increase

ITeos Therapeutics is a biopharmaceutical company whose work is dedicated to designing and developing next generation immunotherapies.

View company